✦ LIBER ✦

584 PREVALENCE OF METABOLIC SYNDROME IN PROSTATE CANCER PATIENTS UNDER ANDROGEN DEPRIVATION THERAPY: INTERIM RESULTS OF A CASE-CONTROL STUDY

✍ Scribed by Ropero, Jorge; Planas, Jacques; Ballesteros, Carlos; Mir, Carme; Placer, José; Raventós, Carles Xavier; Morote, Juan

Book ID: 122367991
Publisher: Lippincott Williams and Wilkins
Year: 2010
Tongue: English
Weight: 46 KB
Volume: 183
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2010.02.843

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1095 PREVALENCE OF METABOLIC SYNDROME IN

1095 PREVALENCE OF METABOLIC SYNDROME IN PROSTATE CANCER PATIENTS UNDER ANDROGEN DEPRIVATION THERAPY: INTERIM RESULTS OF A CASE-CONTROL STUDY

✍ Ropero Valverde, J.; Planas Morin, J.; Salvador Lacambra, C.; Trilla Herrera, E. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 193 KB

Cross-sectional observational study abou

Cross-sectional observational study about prevalence of metabolic syndrome in prostate cancer treated with androgen deprivation therapy (SIMBOSPROST). Group GICOR

✍ Muñoz García, J.; Samper Ots, P.; Ríos Kavadoy, Y.; Couselo Paniagua, M.; Villaf 📂 Article 📅 2013 🏛 Wielkopolskie Centrum Onkologii 🌐 Polish ⚖ 56 KB

351 PREVALENCE OF METABOLIC SYNDROME IN

351 PREVALENCE OF METABOLIC SYNDROME IN PROSTATE CANCER PATIENTS BEFORE AND AFTER 12 MONTHS OF ANDROGEN DEPRIVATION THERAPY: DATA FROM THE MULTICENTRE OBSERVATIONAL ANAMET STUDY

✍ Morote, Juan; Gómez-Caamaño, Antonio; Alvarez-Ossorio, José; Pesqueira, Daniel; 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 53 KB

HIGH PREVALENCE OF METABOLIC SYNDROME IN

HIGH PREVALENCE OF METABOLIC SYNDROME IN PATIENTS UNDER LONG-TERM HORMONAL THERAPY FOR PROSTATE CANCER. PRELIMINARY REPORT

✍ Camara, Cesar; Dall'Oglio, Marcos F; Segre, Carlos A; Shiraishi, Karen S; Hayek, 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 218 KB

Cross-Sectional Observational Study Abou

Cross-Sectional Observational Study About Prevalence of Metabolic Syndrome and Osteoporosis in Prostate Cancer Treated With Androgen Deprivation Therapy and Their Impact on Quality of Life (SIMBOSPROST): GICOR Group

✍ Munoz Garcia, J.; Samper Ots, P.M.; Rios Kavadoy, Y.; Couselo Paniagua, M.L.; Vi 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Androgen deprivation therapy influences

Androgen deprivation therapy influences the uptake of11C-choline in patients with recurrent prostate cancer: the preliminary results of a sequential PET/CT study

✍ Chiara Fuccio; Riccardo Schiavina; Paolo Castellucci; Domenico Rubello; Giuseppe 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 212 KB